Oscar Health, Inc.

Symbol: OSCR

NYSE

14.87

USD

Market price today

  • -95.7939

    P/E Ratio

  • 1.0930

    PEG Ratio

  • 2.89B

    MRK Cap

  • 0.00%

    DIV Yield

Oscar Health, Inc. (OSCR) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

1.00%

Operating Profit Margin

-0.00%

Net Profit Margin

-0.01%

Return on Assets

-0.01%

Return on Equity

-0.06%

Return on Capital Employed

-0.02%

Company general description and statistics

Sector: Healthcare
Industry: Healthcare - Plans
CEO:Mr. Mark Thomas Bertolini
Full-time employees:2400
City:New York
Address:75 Varick Street
IPO:2021-03-03
CIK:0001568651

Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

General Outlook

When we look at how much money they make before expenses, they keep 1.000% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.004%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.008%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.012% return, is a testament to Oscar Health, Inc.'s adeptness in optimizing resource deployment. Oscar Health, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.058%. Furthermore, the proficiency of Oscar Health, Inc. in capital utilization is underscored by a remarkable -0.018% return on capital employed.

Stock Prices

Oscar Health, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $18.03, while its low point bottomed out at $17.08. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Oscar Health, Inc.'s stock market.

Liquidity Ratios

Analyzing OSCR liquidity ratios reveals its financial health of the firm. The current ratio of 116.04% gauges short-term asset coverage for liabilities. The quick ratio (105.64%) assesses immediate liquidity, while the cash ratio (73.88%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio116.04%
Quick Ratio105.64%
Cash Ratio73.88%

Profitability Ratios

OSCR profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -0.78% underscores its earnings before tax deductions. The effective tax rate stands at -4.43%, revealing its tax efficiency. The net income per EBT, 104.63%, and the EBT per EBIT, 207.42%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -0.38%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-0.78%
Effective Tax Rate-4.43%
Net Income per EBT104.63%
EBT per EBIT207.42%
EBIT per Revenue-0.38%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.16, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 1906.09% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding106
Operating Cycle19.15
Cash Conversion Cycle19
Receivables Turnover19.06
Fixed Asset Turnover106.44
Asset Turnover1.48

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.23, and free cash flow per share, -0.33, depict cash generation on a per-share basis. The cash per share value, 12.30, showcases liquidity position. Lastly, the operating cash flow sales ratio, -0.01, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-0.23
Free Cash Flow per Share-0.33
Cash per Share12.30
Operating Cash Flow Sales Ratio-0.01
Free Cash Flow to Operating Cash Flow Ratio1.46
Cash Flow Coverage Ratio-0.18
Capital Expenditure Coverage Ratio-2.17
Dividend Paid and Capex Coverage Ratio-2.17

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 6.77%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.29, we discern the balance between debt and equity financing. The long-term debt to capitalization, 22.46%, and total debt to capitalization, 22.46%, ratios shed light on its capital structure. An interest coverage of -1.01 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio6.77%
Debt Equity Ratio0.29
Long Term Debt to Capitalization22.46%
Total Debt to Capitalization22.46%
Interest Coverage-1.01
Cash Flow to Debt Ratio-0.18
Company Equity Multiplier4.28

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 26.45, provides a glimpse into top-line earnings distributed across each share. Net income per share, -1.22, reflects the portion of profit attributed to each share. The book value per share, 3.63, represents the net asset value distributed per share, while the tangible book value per share, 3.64, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share26.45
Net Income Per Share-1.22
Book Value Per Share3.63
Tangible Book Value Per Share3.64
Shareholders Equity Per Share3.63
Interest Debt Per Share1.46
Capex Per Share-0.12

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 42.11%, indicates top-line expansion, while the gross profit growth, 42.11%, reveals profitability trends. EBIT growth, 59.67%, and operating income growth, 59.67%, offer insights into operational profitability progression. The net income growth, 55.59%, showcases bottom-line expansion, and the EPS growth, 57.49%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth42.11%
Gross Profit Growth42.11%
EBIT Growth59.67%
Operating Income Growth59.67%
Net Income Growth55.59%
EPS Growth57.49%
EPS Diluted Growth57.49%
Weighted Average Shares Growth4.32%
Weighted Average Shares Diluted Growth4.32%
Operating Cash Flow Growth-171.56%
Free Cash Flow Growth-184.74%
10-Year Revenue Growth per Share39.77%
5-Year Revenue Growth per Share39.77%
3-Year Revenue Growth per Share31.27%
10-Year Operating CF Growth per Share78.27%
5-Year Operating CF Growth per Share78.27%
3-Year Operating CF Growth per Share-116.13%
10-Year Net Income Growth per Share86.32%
5-Year Net Income Growth per Share86.32%
3-Year Net Income Growth per Share91.21%
SGA Expenses Growth9.66%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 456,609,760.95, captures the company's total value, considering both debt and equity. Income quality, 1.01, assesses the reliability of reported earnings.

cards.indicatorcards.value
Enterprise Value456,609,760.95
Income Quality1.01
Sales General and Administrative to Revenue0.06
Capex to Operating Cash Flow9.40%
Capex to Revenue-0.44%
Capex to Depreciation-83.33%
Stock-Based Compensation to Revenue2.72%
Graham Number9.98
Return on Tangible Assets-8.06%
Graham Net Net-5.19
Working Capital632,088,000
Tangible Asset Value806,117,000
Net Current Asset Value265,737,000
Average Receivables826,805,500
Average Payables529,940,500
Average Inventory-2,106,879,500
Days Sales Outstanding31
ROIC-21.63%
ROE-0.34%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 4.97, and the price to book ratio, 4.97, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.68, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -58.29, and price to operating cash flows, -97.76, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio4.97
Price to Book Ratio4.97
Price to Sales Ratio0.68
Price Cash Flow Ratio-97.76
Price Earnings to Growth Ratio1.09
Enterprise Value Multiple-352.19
Price Fair Value4.97
Price to Operating Cash Flow Ratio-97.76
Price to Free Cash Flows Ratio-58.29
Price to Tangible Book Ratio2.52
Enterprise Value to Sales0.08
Enterprise Value Over EBITDA-1.94
EV to Operating Cash Flow-1.68
Earnings Yield-13.35%
Free Cash Flow Yield-14.68%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast
Similar Stocks
You may also be interested in:

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Oscar Health, Inc. (OSCR) on the NYSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -95.794 in 2024.

What is the ticker symbol of Oscar Health, Inc. stock?

The ticker symbol of Oscar Health, Inc. stock is OSCR.

What is company IPO date?

IPO date of Oscar Health, Inc. is 2021-03-03.

What is company current share price?

Current share price is 14.870 USD.

What is stock market cap today?

The market cap of stock today is 2887947310.000.

What is PEG ratio in 2024?

The current 1.093 is 1.093 in 2024.

What is the number of employees in 2024?

In 2024 the company has 2400.